Annual report pursuant to Section 13 and 15(d)

ABEONA THERAPEUTICS LLC ACQUISITION (Details)

v3.3.1.900
ABEONA THERAPEUTICS LLC ACQUISITION (Details)
 12 Months Ended
May. 15, 2015
USD ($)
Milestone
$ / shares
shares
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Total purchase price [Abstract]      
Initial consideration   $ 31,758,000 $ 0
Allocation of the purchase price [Abstract]      
Goodwill   32,466,000 0
Contingent consideration liability   2,591,000 $ 0
Abeona Therapeutics LLC [Member]      
Business Acquisition [Line Items]      
Stock issued in acquisition (in shares) | shares 3,979,761    
Business acquisition, share price (in dollars per shares) | $ / shares $ 7.98    
Number of shares issued to company (in shares) | shares (3,979,761)    
Number of milestones | Milestone 3    
Total purchase price [Abstract]      
Initial consideration $ 31,758,000    
Contingent consideration 6,489,000    
Total purchase price 38,247,000    
Allocation of the purchase price [Abstract]      
Cash 3,697,000    
Accounts receivable 1,000    
Prepaid expenses 28,000    
Property and equipment 51,000    
Other assets 1,000    
Accounts payable (153,000)    
Total tangible assets 3,625,000    
Licensing agreement 2,156,000    
Goodwill 32,466,000    
Total net asset value 38,247,000    
Acquisition transaction cost $ 375,000    
Contingent consideration liability   $ 3,898,000